Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver
Saved in:
| Published in: | Molecular Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552791764500480 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Molecular Oncology |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:61250 |
| institution | FRELIP |
| journal_source_facet | Molecular Oncology |
| last_indexed | 2026-06-20T21:26:42.861Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver |
| title_alt | El FGF19 derivado de cáncer colorrectal es un biomarcador sérico metabólicamente activo que ejerce efectos enteroendocrinos en el hígado de ratón Le FGF19 dérivé du cancer colorectal est un biomarqueur sérique métaboliquement actif qui exerce des effets entéroendocriniens sur le foie de souris FGF19 derivado de câncer colorretal é um biomarcador sérico metabolicamente ativo que exerce efeitos enteroendócrinos no fígado de camundongos |
| title_auth | Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver |
| title_es_txt | El FGF19 derivado de cáncer colorrectal es un biomarcador sérico metabólicamente activo que ejerce efectos enteroendocrinos en el hígado de ratón |
| title_fr_txt | Le FGF19 dérivé du cancer colorectal est un biomarqueur sérique métaboliquement actif qui exerce des effets entéroendocriniens sur le foie de souris |
| title_full | Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver |
| title_fullStr | Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver |
| title_full_unstemmed | Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver |
| title_pt_txt | FGF19 derivado de câncer colorretal é um biomarcador sérico metabolicamente ativo que exerce efeitos enteroendócrinos no fígado de camundongos |
| title_short | Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver |
| title_sort | colorectal cancer‐derived fgf19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver |
| topic | Oncology General Oncology |
| url | https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70212?af=R |